ArticleFrontiers in oncology2023

The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs.

Weiguo Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.